Found: 7
Select item for more details and to access through your institution.
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2631, doi. 10.1007/s00262-022-03185-6
- By:
- Publication type:
- Article
Loss of Tid1/DNAJA3 Co-Chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: A Novel Model to Stratify Risk of Recurrence.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 138, doi. 10.3390/cancers13010138
- By:
- Publication type:
- Article
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1862, doi. 10.3390/cancers12071862
- By:
- Publication type:
- Article
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 182, doi. 10.3390/cancers12010182
- By:
- Publication type:
- Article
Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article